The blood pressure response to antihypertensive treatment with lisinopril or bendrofluazide is related to the calcium and magnesium contents in skeletal muscle

American Journal of Hypertension

Volumn 9, Issue 3, 1996, Pages 273-276

  Haenni, Arvo ^a   Lind, Lars ^a   Lithell, Hans ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Bendrofluazide; Calcium; Hypertension; Lisinopril; Magnesium; Muscle minerals

Indexed keywords

BENDROFLUMETHIAZIDE; CALCIUM; LISINOPRIL; MAGNESIUM;

ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG RESPONSE; DRUG TISSUE LEVEL; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; MALE; MUSCLE BIOPSY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKELETAL MUSCLE;

EID: 0029878234     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/0895-7061(95)00399-1     Document Type: Article

References (19)

1. Resnick LM, Gupta RK, Bhargava KK, et al: Cellular ions in hypertension, diabetes and obesity. A nuclear magnetic resonance spectroscopy study. Hypertension 1991;17:951-957.
2. Lindner A, Hinds TR, Davidson RC, et al: Increased cytosolic free calcium in red blood cells is associated with essential hypertension in humans. Am J Hypertens 1993;6:771-779.
3. Erne P, Bolli P, Burgisser E, et al: Correlation of platelet calcium with blood pressure: effect of antihypertensive therapy. N Engl J Med 1984;310:1084-1088.
4. Pritchard K, Raine AEG, Ashley CC, et al: Correlation of blood pressure in normotensive and hypertensive individuals with platelet but not lymphocyte intracellular free calcium concentrations. Clin Sci 1989;76:631-635.
5. Haenni A, Andersson PE, Lind L, et al: Electrolyte changes and metabolic effects of lisinopril / bendrofluazide treatment. Am J Hypertens 1994;7:615-622.
6. Bergström J: Muscle electrolytes in man. Scand J Clin Lab Invest 1962;14(suppl 68):1-110.
7. Paolisso G, Gambardella A, Balbi V, et al: Effects of magnesium and nifedipine infusions on insulin action, substrate oxidation, and blood pressure in aged hypertensive patients. Am J Hypertens 1993;6:920-926.
8. Resnick LM, Bardicef O, Bardicef M, et al: Intracellular tissue magnesium deficiency in human essential hypertension. Am J Hypertens 1994;7:63A.
9. Stull JT, Gallagher PJ, Herring BP, et al: Vascular smooth muscle contractile elements. Cellular regulation. Hypertension 1991;17:723-732.
10. Altura B, Altura B: Role of magnesium ions in contractility of blood vessels and skeletal muscle. Magnesium Bull 1981;3:102-111.
11. Nakayama K, Fleckenstein A, Byon YK, et al: Fundamental physiology of coronary smooth musculature from extramural stem arteries of pigs and rabbits (electric excitability, tension development, influence of Ca, Mg, H and K ions). Eur J Cardiol 1978;8:319-335.
12. Dyckner T, Wester PO: Effect of magnesium on blood pressure. Br Med J 1983;286:1847-1849.
13. Wester PO, Dyckner T: Magnesium and hypertension. J Am Coll Nutr 1987;6:321-328.
14. + pump. Am J Physiol 1993;264(2 pt 1):C457-C463.
15. Whang R, Whang D, Ryan M: Refractory potassium repletion. Arch Intern Med 1992;152:40-45.
16. Whang R, Whang D: Update: mechanisms by which magnesium modulates intracellular potassium. J Am Coll Nutr 1990;9:84-85.
17. Ryan M, Whang R: Interrelationships between potassium and magnesium, in Whang R (ed) : Potassium: Its Biological Significance. Boca Raton, CRC Press, 1983, pp 97-107.
18. Shine KI, Douglas AM: Magnesium effects on ionic exchange and mechanical function in rat ventricle. Am J Physiol 1974;227:317-324.
19. Duchatelle-Gourdon I, Hartzell HC, Lagrutta AA: Modulation of the delayed rectifier potassium current in frog cardiomyocytes by beta-adrenergic agonists and magnesium. J Physiol 1989;415:251-274.